{"id":"W2739116172","doi":"10.1200/jco.2017.35.15_suppl.9506","title":"COMBI-MB: A phase II study of combination dabrafenib (D) and trametinib (T) in patients (pts) with <i>BRAF</i> V600–mutant (mut) melanoma brain metastases (MBM).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Cohort; Internal medicine; Asymptomatic; Metastatic melanoma; Melanoma; Oncology; Phases of clinical research; Regimen; Gastroenterology; Clinical trial; Cancer; Vemurafenib; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001978687,0.0001961595,0.00132636,0.0000630787,0.0002009715,0.00002660197,0.000527293,0.000269211,0.0001224711],"category_scores_gemma":[0.003258632,0.000152522,0.000164423,0.00008546558,0.0003991139,0.0002149404,0.0001683368,0.0008107487,0.000001110098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005957541,"about_ca_system_score_gemma":0.000303345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004593419,"about_ca_topic_score_gemma":0.0001355695,"domain_scores_codex":[0.9965942,0.0002192404,0.0022929,0.0003018902,0.0003820641,0.0002097082],"domain_scores_gemma":[0.9928092,0.002247354,0.003862346,0.0005141463,0.0003260472,0.0002409322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01190285,0.1839117,0.5762992,0.0001949034,0.001032992,0.0003646431,0.001444888,0.00002014879,0.01295485,0.0003856068,0.001508821,0.2099794],"study_design_scores_gemma":[0.3860334,0.1111929,0.3920422,0.0006439841,0.001747381,0.0002892911,0.004097776,0.0003134464,0.05327341,0.002858136,0.0464122,0.001095917],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957929,0.00002737076,0.00001059212,0.002129006,0.00008530582,0.0002104593,0.00004571824,0.000007192926,0.001691497],"genre_scores_gemma":[0.9992829,0.00003308028,0.0002438603,0.0001596145,0.0001183166,0.00001500952,0.00001484156,0.00001696822,0.0001153995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3741305,"threshold_uncertainty_score":0.6219667,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07614107715406832,"score_gpt":0.4387251507223836,"score_spread":0.3625840735683152,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}